Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5studies shown
Showing 1-5 of 5
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in multiple countries, including in the United States, in Argentina, and in Australia. It is testing KarXT for manic episodes in bipolarity type I.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

This study is recruiting in multiple countries, including in the United States, in Argentina, and in Australia. It is testing KarXT for manic episodes in bipolarity type I.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
RecruitingISRCTN12329547

study of a digital depression management application: juli

This study is looking at whether a digital support tool can help people with Depression, Mental and Behavioural Disorders, or Depressive episode, unspecified. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom, Afghanistan, Finland, Albania, Algeria, United States, Andorra, Angola, Antarctica, Antigua and Barbuda, Argentina, Armenia, Netherlands, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Norway, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Congo, Democratic Republic, New Zealand, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Côte d'Ivoire, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Vatican City, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Federated States of, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, North Macedonia, Oman, Pakistan, Palau, Palestine, State of, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkmenistan, Tuvalu, Turkey, Uganda, Ukraine, United Arab Emirates, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Western Sahara, Yemen, Zambia, Zimbabwe
Sponsor
University College London
Condition
Depression
RecruitingISRCTN18437856

Intelligent depression tracking

This observational study is following people with Depressive symptoms, including anxiety and other mental and/or chronic physical health comorbidities or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 99 Years
Countries
United Kingdom, Australia, Canada, Ireland, New Zealand, United States
Sponsor
Thymia Limited
Condition
Depression
New Zealand | Clinical Trials | HopeStage Research